Regeneron Pharma (REGN) PT Raised to $900 at Wolfe Research
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $799.08 +0.62%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
Wolfe Research analyst Alexandria Hammond raised the price target on Regeneron Pharma (NASDAQ: REGN) to $900.00 (from $800.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Morgan Stanley Upgrades DNB ASA (DNB:NO) (DNHBY) to Equalweight
- Antero Resources (AR) PT Raised to $55 at Raymond James
- Morgan Stanley Downgrades Nordea Bank Abp (NDA:SS) (NRDBY) to Equalweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
